π CPT 30630 β Repair Nasal Septal Perforations
Quick Reference
wRVU: 7.11 | Global Period: 090 (90 days) | Assistant Payable: β Yes | Bilateral Indicator: 0
π Clinical Description
CPT 30630 describes the surgical repair of a nasal septal perforation β a through-and-through hole in the nasal septum that creates an abnormal communication between the two nasal cavities. The classic technique, as described in the AMA Coderβs Desk Reference and confirmed by AAPC otolaryngology guidance, involves the creation of bilateral mucoperichondrial flaps (also called mucoperichondrial advancement flaps) on each side of the perforation. A scalpel is used to elevate each flap so that it exposes one side of the septal cartilage while retaining mucosal coverage on the opposite side. The flaps are advanced to cover the perforation and sutured in a single or double layer, restoring the mucosal lining on both nasal surfaces. For larger perforations, an interposition graft β autologous cartilage (septal, conchal, or costal), temporalis fascia, acellular dermal matrix (ADM), or pericranium β is placed between the two mucosal layers to provide structural support and reduce recurrence risk. 30630 covers the perforation repair regardless of graft type or perforation size β there is no separate code for small vs. large perforations, and graft harvest (e.g., 20912 for cartilage graft, nasal septum) may be separately reportable. [web:97][web:98]
The key distinction between 30630 and 30520 (septoplasty) is the clinical objective: 30520 removes, repositions, or scores septal cartilage to correct a deviated septum causing nasal obstruction. 30630 adds tissue to repair a hole in the septum. If an operative note describes removing cartilage to straighten the septum (without a perforation), 30520 is correct. If the note describes covering a hole with flaps or grafts, 30630 applies. These two procedures may co-exist and be separately reportable β a patient may have both a septal deviation (requiring 30520) and a perforation (requiring 30630) addressed at the same session, with modifier -51 on the lower-valued code β but the operative note must clearly document each distinct problem and its distinct repair.
This procedure may be performed in the following clinical contexts:
- Post-surgical septal perforation β The most common etiology in the rhinologic surgical population; prior septoplasty, submucous resection, or cauterization created opposing mucosal injuries that healed as a through-and-through defect; document prior surgical history and confirm perforation location relative to the prior surgical site.
- Cocaine-induced septal perforation β Intranasal cocaine use causes ischemic necrosis of the septal mucosa and cartilage through vasoconstriction; typically anterior, and may be large if use was prolonged; repair should be deferred until confirmed cessation of cocaine use; document cessation and drug screening compliance in the pre-operative record to support medical necessity.
- Post-traumatic septal perforation β Direct nasal trauma causing bilateral septal mucosal lacerations that heal as a perforation; also a complication of nasal septal hematoma that was not drained or that became infected (septal abscess); document the traumatic event and confirm no osteomyelitis or active infection before repair.
- Idiopathic or chronic inflammatory perforation β Some perforations have no identifiable cause; others result from chronic granulomatous inflammation (granulomatosis with polyangiitis / Wegenerβs, sarcoidosis, cocaine levamisole adulteration, or chronic topical corticosteroid over-use); the underlying systemic condition must be medically controlled before surgical repair β document the pre-operative disease control status.
- Congenital nasal septal perforation β Rare; document the congenital nature with ICD-10 Q30.3; surgical repair indications are similar to acquired perforations (crusting, epistaxis, whistling, obstruction).
π¬ Anatomical & Procedural Considerations
| Repair Technique | Clinical Application | Key Coding & Clinical Notes |
|---|---|---|
| Bilateral Mucoperichondrial Advancement Flaps (Standard) | Hemitransfixion incision made; bilateral flaps elevated off the septal cartilage; flaps advanced to cover the perforation from each side; closed in a single or double mucosal layer | Classic technique; most common approach for small to moderate perforations (< 1.5-2 cm); document flap design, perforation size, and layer-by-layer closure in the operative note |
| Rotational or Transposition Mucosal Flap | A rotational flap incorporating adjacent inferior turbinate mucosa or floor-of-nose mucosa is designed and transposed to cover a larger or posteriorly located perforation | Reserved for larger or more posteriorly located defects where simple bilateral advancement cannot achieve tension-free closure; document the specific flap type (rotation, transposition, island) and the pedicle used |
| Interposition Graft β Autologous Cartilage | Cartilage harvested from the nasal septum (20912), ear (conchal cartilage β 21235), or rib (20900/20902) is placed between the two mucosal layers to provide structural support and reduce recurrence | Graft harvest is separately reportable β report the appropriate cartilage or bone graft harvest code with modifier -51; document donor site explicitly; cartilage graft harvest adds to the surgical complexity and supports modifier -22 consideration for large perforations |
| Interposition Graft β Temporalis Fascia / Pericranium | Fascial graft harvested from the temporal region is placed as an interposition layer between the two mucosal flaps | Fascial graft harvest may be separately reportable β confirm NCCI edits; document donor site (temporal fascia, pericranium) and graft application |
| Acellular Dermal Matrix (ADM) Interposition | ADM (e.g., Alloderm, Biodesign, or similar product) placed as an off-the-shelf interposition layer, eliminating the need for a donor site | The 30630 code covers the procedural service; ADM graft material is reported separately using the appropriate HCPCS supply code for the specific product; document product name, lot number, and size in the operative note |
| Prosthetic Septal Button Placement (30220) | In patients who are not surgical candidates for formal repair, a silicone nasal septal button prosthesis may be inserted as palliation | 30220 (Insertion, nasal septal prosthesis) is a distinct code and is not reported alongside 30630 at the same session β a prosthesis insertion is not a repair; report 30220 for button insertion and 30630 for formal surgical repair as distinct encounters |
Clinical Pearl
The most important documentation elements for 30630 are: (1) confirmation that a through-and-through perforation exists (not merely a mucosal ulceration or thinning), (2) perforation size (measured in mm or cm β required to support modifier -22 for large perforations), (3) the specific repair technique (bilateral mucoperichondrial flaps, rotational flap, interposition graft type), and (4) the etiology of the perforation (post-surgical, cocaine-induced, traumatic, vasculitic, idiopathic). The etiology drives the ICD-10-CM code selection and β critically for cocaine-induced perforations β the pre-operative documentation of cessation that supports medical necessity for the repair. Without documentation of cessation, payers may deny the claim as premature intervention or medically unnecessary given the risk of recurrence with continued use.
β Procedure Includes
- Pre-operative nasal endoscopy or examination confirming the perforation location, size, and mucosal quality
- General anesthesia (separately billable by the anesthesia provider)
- Hemitransfixion or Killian incision for septal access
- Elevation of bilateral mucoperichondrial flaps on both sides of the nasal septum to expose the perforation margins
- Excision or freshening of the perforation edges to create a vascularized tissue bed
- Flap advancement and tension-free closure of the nasal mucosal layer on each side
- Placement of interposition graft material when used β cartilage, fascia, or ADM (graft harvest separately reportable if autologous)
- Internal nasal splints or septal sutures (quilting sutures) to maintain apposition of the repaired septal surfaces
- Post-operative nasal packing, when placed, for hemostasis (included)
- Wound closure of external incisions (if open rhinoplasty approach is used)
β Excludes / Do Not Report Together
| Code | Description | Relationship to 30630 |
|---|---|---|
| 30520 | Septoplasty or submucous resection, with or without cartilage scoring, contouring, or replacement with graft | Separately reportable when a true septal deviation is ALSO corrected at the same session alongside the perforation repair β document each distinct problem (deviation AND perforation) and each distinct repair technique in the operative note; apply modifier -51 to the lower-valued code; do not report 30520 if the only septal work was the flap elevation required for 30630 |
| 30220 | Insertion, nasal septal prosthesis (button) | Mutually exclusive at the same session β 30220 describes insertion of a silicone button as a palliative prosthesis; 30630 describes definitive surgical repair; these are distinct treatment approaches for the same condition at two different time points; do not report both for the same date of service |
| 20912 | Cartilage graft; nasal septum | Separately reportable when septal cartilage is harvested from a distant site (remaining intact septum) and used as interposition graft material for the repair; confirm NCCI edit status and apply modifier -51; document the graft harvest location, amount harvested, and its use in the repair |
| 21235 | Graft; ear cartilage, autogenous, to nose | Separately reportable when conchal ear cartilage is harvested as an interposition graft for the perforation repair; report with modifier -51; document the ear donor site and graft application |
| 30600 | Repair fistula; oronasal | Different anatomic entity β 30600 repairs a communication between the oral and nasal cavities through the hard palate; 30630 repairs a communication between the two nasal cavities through the septum; these are distinct procedures and may theoretically co-exist but are not confused for the same anatomic problem |
| 30400-30462 | Rhinoplasty codes (primary and secondary) | Rhinoplasty may be performed concurrently with septal perforation repair β common when the patient also has a nasal deformity or saddle nose deformity from cartilage loss; rhinoplasty codes are separately reportable with modifier -51; ensure each procedure is distinctly documented with independent clinical indications; rhinoplasty for cosmetic reasons without a functional or structural indication separate from the perforation is subject to coverage restriction |
| E/M codes (992xx / 920xx) | Office visit or hospital visit, any level | Separately reportable only when modifier -25 is appended to the E/M code, documenting a significant, separately identifiable evaluation beyond the routine pre-procedure assessment |
Bundling Alert β Global Period is 090 (90 days)
CPT 30630 carries a 90-day global period, meaning all routine post-operative care β wound checks, nasal splint removal, crusting management, post-operative endoscopy for healing assessment, and nasal irrigation counseling β is bundled for 90 days. Nasal debridement visits within the 90-day global window are a common audit focus β if the surgeon performs nasal debridement under direct visualization at a post-operative visit during the global period, that service is bundled and cannot be separately billed unless it meets the criteria for an unrelated or unplanned OR return service. Planned staged procedures (e.g., a planned secondary rhinoplasty or secondary repair if the initial closure fails) require modifier -58, which opens a new global period. Unrelated surgical procedures during the global window require modifier -79.
π³ Code Tree β Surgery: Respiratory System β Repair Procedures on the Nose
CPT 30400-30630 Repair Procedures on the Nose
β
βββ 30400 Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip (Global: 090)
βββ 30410 Rhinoplasty, primary; complete, external parts including bony pyramid, lateral and alar cartilages, and/or elevation of nasal tip (Global: 090)
βββ 30420 Rhinoplasty, primary; including major septal repair (Global: 090)
βββ 30430 Rhinoplasty, secondary; minor revision (small amount of nasal tip work) (Global: 090)
βββ 30435 Rhinoplasty, secondary; intermediate revision (bony work with osteotomies) (Global: 090)
βββ 30450 Rhinoplasty, secondary; major revision (nasal tip work and osteotomies) (Global: 090)
βββ 30460 Rhinoplasty for nasal deformity incident to congenital cleft lip and/or palate; tip only (Global: 090)
βββ 30462 Rhinoplasty for nasal deformity incident to congenital cleft lip and/or palate; tip, septum, osteotomies (Global: 090)
β
βββ 30520 Septoplasty or submucous resection, with or without cartilage scoring, contouring or replacement with graft (Global: 090)
β
βββ 30540 Repair choanal atresia; intranasal (Global: 090)
βββ 30545 Repair choanal atresia; transpalatine (Global: 090)
βββ 30560 Lysis intranasal synechia (Global: 090)
βββ 30580 Repair fistula; oromaxillary (Global: 090)
βββ 30600 Repair fistula; oronasal (Global: 090)
β
βββ βΆβΆ 30630 ββ Repair nasal septal perforations β YOU ARE HERE (Global: 090)
π° RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 7.11 (CMS RVU26A; verify against current MPFS for applicable year) |
| Practice Expense RVU (Non-Facility) | ~10.02 |
| Malpractice RVU | ~1.07 |
| Total Non-Facility RVU | ~18.20 |
| Estimated Medicare Payment (Non-Facility, 2026) | ~33.40; actual payment varies by locality GPCI)* |
| Global Period | 090 (90 days) |
| Bilateral Indicator | 0 β Not a bilateral procedure; the nasal septum is a single midline structure; bilateral indicator 0 means standard 150% bilateral reduction rules do not apply; modifier -50 is NOT applicable to 30630 |
| Assistant Surgeon | β Payable β Modifier -80 (or -82 if qualified resident not available); document medical necessity; commonly appropriate for large perforations requiring concurrent rhinoplasty or free flap reconstruction |
| Co-Surgeon | β Applicable β Modifier -62 when two surgeons of different specialties each perform distinct non-overlapping portions concurrently; document each surgeonβs contribution |
| Team Surgery | β Not applicable for isolated septal perforation repair |
| PC/TC Split | β No β Procedure code only (Indicator 0) |
| Modifier -51 Exempt | No β Subject to multiple procedure reduction rules when billed with other surgical procedures at the same session |
| Anesthesia | General anesthesia is standard; separately billable by the anesthesia provider under CPT 00160 (anesthesia for procedures on nose and accessory sinuses; not otherwise specified) or 00162 (anesthesia for complex procedures on nose/sinus); surgeon does NOT bill for anesthesia |
Bilateral Billing Rules
30630 has a bilateral indicator of 0 β modifier -50 is never appropriate for this code. The nasal septum is a single midline structure; there is no right-side or left-side component to separately bill. The repair involves both sides of the septum by definition (bilateral mucoperichondrial flaps), but this is the inherent nature of the procedure β not a bilateral service in the payer reimbursement sense. Applying -50 to 30630 will result in claim rejection or recoupment and is a compliance error. When concurrent procedures are performed that have bilateral components (e.g., bilateral inferior turbinate reduction), those procedures are separately coded β the bilateral indicator and -50 considerations apply to those codes individually, not to 30630.
π·οΈ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -22 | Increased Procedural Services | When the perforation repair required substantially greater work than typical β e.g., large perforation (> 1.5-2 cm), prior failed repair attempt(s), scarred/atrophic mucosa from prior surgery or cauterization, post-radiation tissue, systemic vasculitis affecting tissue quality, prolonged operative time; operative note must document specific complexity factors (perforation size, tissue quality, flap design, operative time); attach a cover letter to the claim |
| -25 | Significant, Separately Identifiable E/M | Applied to the E/M code β not 30630 β when a significant, separately identifiable evaluation is performed same date; uncommon on the day of a major surgical procedure |
| -24 | Unrelated E/M During Postoperative Period | Applied to the E/M code when the patient returns within the 90-day global window for a condition unrelated to the perforation repair; document the unrelated nature explicitly |
| -51 | Multiple Procedures | When 30630 is performed alongside other separately reportable surgical procedures at the same session β e.g., concurrent 30520 (septoplasty), rhinoplasty codes (30400-30462), turbinate procedures (30130, 30140), or cartilage graft harvest (20912, 21235); apply -51 to the lower-valued code |
| -59 | Distinct Procedural Service | When 30630 is billed alongside a procedure that payers may bundle inappropriately β documents distinct anatomic site or independent service |
| XS | Separate Structure | Preferred over -59 when the distinct service involves a clearly separate anatomic structure β e.g., 30630 alongside 30130 (inferior turbinate excision) |
| -54 | Surgical Care Only | Surgeon performs the repair but post-operative care (nasal packing management, splint removal, wound checks) is assumed by a different provider; 90-day global must be split; both providers must coordinate claims |
| -55 | Postoperative Management Only | Provider assuming post-operative care during the 90-day global after surgery was performed by a different surgeon (e.g., local ENT assuming care for a patient who traveled for surgery) |
| -58 | Staged or Related Procedure | Planned staged procedure during the 90-day global β e.g., planned secondary repair if initial closure fails, planned rhinoplasty staged after perforation repair healing, planned cartilage graft augmentation; opens a new global period |
| -62 | Two Surgeons | When two surgeons of different specialties perform distinct, non-overlapping portions concurrently β e.g., ENT performs septal perforation repair while facial plastic surgeon simultaneously performs structural rhinoplasty; both surgeons append -62 and document their distinct contributions |
| -76 | Repeat Procedure by Same Physician | Repair of a recurrent perforation (failed closure) by the original surgeon; document the recurrence finding and clinical justification |
| -77 | Repeat Procedure by Different Physician | Revision repair performed by a different surgeon |
| -78 | Unplanned Return to OR | Unplanned return for a complication during the 90-day global β e.g., post-operative septal hematoma, wound dehiscence with re-perforation, significant post-operative hemorrhage |
| -79 | Unrelated Procedure During Postoperative Period | Unrelated surgical procedure during the 90-day global window |
| -80 | Assistant Surgeon | When an assistant surgeon participates; document medical necessity |
| -81 | Minimum Assistant Surgeon | When minimal assistant surgeon involvement is required |
| -82 | Assistant Surgeon When Qualified Resident Not Available | Teaching hospital setting where a qualified resident is not available |
π©Ί Common ICD-10-CM Pairings
Acquired Nasal Septal Perforation β Primary Diagnoses
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| J34.89 | Other specified disorders of nose and nasal sinuses | β No | Most commonly used primary code for acquired nasal septal perforation β ICD-10-CM does not have a specific code for βacquired nasal septal perforationβ; J34.89 is the most appropriate code for post-surgical, cocaine-induced, traumatic, idiopathic, and inflammatory perforations in the absence of a more specific code; document the etiology explicitly in the clinical record even though the ICD-10 code does not differentiate by cause |
| Q30.3 | Congenital perforated nasal septum | β No | Use only for perforations that are congenital in origin β present from birth or early infancy without an acquired etiology; confirm congenital status with the clinical history; do not use for acquired perforations regardless of how long they have been present |
| S09.92XA | Unspecified injury of nose, initial encounter | β No | Use for perforations of direct traumatic origin β nasal trauma causing bilateral mucosal lacerations that healed as a perforation; 7th character A = initial encounter for the repair; document the traumatic mechanism in the clinical record |
Etiology-Specific Secondary / Comorbid Diagnoses
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| F14.10 | Cocaine abuse, uncomplicated | β No | Report as secondary diagnosis when cocaine-induced ischemic necrosis is the documented etiology; documents the causative substance use disorder; supports medical necessity for the repair (with concurrent documentation of cessation) and reinforces the need for pre-operative drug screening |
| F14.20 | Cocaine dependence, uncomplicated | β No | Use when cocaine dependence (rather than abuse) is the documented diagnosis β confirm provider documentation differentiates abuse vs. dependence using DSM-5 criteria; report as secondary |
| M31.30 | Wegenerβs granulomatosis without renal involvement | β HCC | Use when granulomatosis with polyangiitis (GPA/Wegenerβs) is the documented systemic cause of the septal perforation; this is an HCC code and will affect risk adjustment; confirm pre-operative disease control status (ANCA titers, rheumatology clearance) is documented in the pre-operative record |
| M31.31 | Wegenerβs granulomatosis with renal involvement | β HCC | Use when GPA with concurrent renal disease is documented; the renal comorbidity is the distinction from M31.30; this is a significant CC/MCC in the inpatient DRG world and affects complication risk in the surgical record |
| D86.0 | Sarcoidosis of lung | β HCC | Report as secondary diagnosis when pulmonary sarcoidosis with nasal septal involvement is the documented etiology of the perforation; confirm disease control pre-operatively |
| L98.499 | Non-pressure chronic ulcer of skin of other sites with unspecified severity | β No | Use for cocaine levamisole adulteration-induced necrosis or other chemical-induced ulcerative/necrotic processes of the septum when the mechanism is mucosal ulceration progressing to perforation; confirm the clinical picture matches this codeβs intent |
| Z79.899 | Other long-term (current) drug therapy | β No | Report when the patient is on chronic medication that may have contributed to the perforation (e.g., intranasal corticosteroid overuse, immunosuppressive therapy for vasculitis); supports complexity documentation and medical necessity narrative |
| Z87.891 | Personal history of other specified conditions | β No | Report on follow-up encounters documenting history of prior septal perforation repair; not applicable on the operative date |
Coding Specificity Reminder β The J34.89 Gap
ICD-10-CM does not have a dedicated code for acquired nasal septal perforation β a significant specificity gap given how common this condition is. J34.89 (other specified disorders of nose and nasal sinuses) is the only appropriate option for most acquired perforations. The etiology β post-surgical, cocaine-induced, vasculitic, traumatic, idiopathic β must be documented in the clinical record for medical necessity and audit defense purposes even though the code does not distinguish between them. When a systemic disease (GPA, sarcoidosis) is the cause, the systemic disease code should be reported as a secondary diagnosis to provide the clinical context that J34.89 alone cannot convey. When the repair is performed for a congenital perforation, use Q30.3 β not J34.89.
π₯ MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 30630 is performed almost exclusively in the outpatient hospital or ASC setting. Inpatient admission for isolated septal perforation repair is not supported by standard utilization review criteria. If a patient with a significant systemic disease (e.g., active GPA with renal involvement, immunocompromise from transplant or HIV) requires post-operative monitoring that exceeds outpatient capability, inpatient admission may be justified β document the specific inpatient criteria clearly. When inpatient, the ICD-10-PCS code (see below) is required. The procedure maps to MDC 03 (Diseases and Disorders of the Ear, Nose, Mouth, and Throat), grouping to DRG 133 / 134 / 135 (Other Ear, Nose, Mouth, and Throat O.R. Procedure with MCC / with CC / without CC/MCC). Active GPA (M31.30 / M31.31) is a significant comorbidity that may qualify as an MCC or CC depending on the specific presentation and tier assignment β CDI querying for the vasculitic diagnosis detail is essential for optimal DRG capture in this population.
π§ ICD-10-PCS Equivalents (Inpatient Facility Coding)
Note
Inpatient PCS coding for 30630 is uncommonly encountered. The PCS root operation depends on the specific technique: Repair (Q) applies when the surgeon restores the septum to its normal anatomic structure using only flap advancement without a graft device. Replacement (R) applies when the septum is repaired using a tissue substitute that physically replaces or augments the structural integrity of the septum β cartilage graft (autologous β value 7), ADM or synthetic (synthetic substitute β J), or nonautologous graft (K). The approach is Open (0) for all standard septal perforation repairs, as the surgeon accesses the septum through the nostril via hemitransfixion or Killian incision β note that PCS defines βOpenβ as cutting through skin or mucous membrane to expose the site, which applies here.
| PCS Code | Full Description | Applicable Scenario |
|---|---|---|
09QM0ZZ | Repair Nasal Septum, Open Approach, No Device, No Qualifier | Bilateral mucoperichondrial flap repair without graft interposition β pure flap-based closure of the perforation; Repair (Q) root operation |
09RM07Z | Replacement of Nasal Septum with Autologous Tissue Substitute, Open Approach, No Qualifier | Repair with autologous cartilage or fascia graft interposition (septal, conchal, costal, or temporal fascia); Replacement (R) root operation; device value 7 = autologous |
09RM0JZ | Replacement of Nasal Septum with Synthetic Substitute, Open Approach, No Qualifier | Repair with ADM (acellular dermal matrix) or synthetic mesh interposition; device value J = synthetic substitute |
09RM0KZ | Replacement of Nasal Septum with Nonautologous Tissue Substitute, Open Approach, No Qualifier | Repair with processed nonautologous tissue graft (e.g., cadaveric cartilage, processed pericardium) interposition; device value K = nonautologous tissue substitute |
PCS Character Analysis β 09QM0ZZ
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | 9 | Ear, Nose, Sinus |
| 3 | Root Operation | Q | Repair (restoring a body part to its normal anatomic structure and function to the extent possible β applies when no device is placed to replace or augment the repaired tissue) |
| 4 | Body Part | M | Nasal Septum |
| 5 | Approach | 0 | Open (access through the nostril via hemitransfixion incision, cutting through the mucous membrane to expose the septal cartilage β PCS defines Open as cutting through the skin or mucous membrane and body layers to expose the site) |
| 6 | Device | Z | No Device (flap repair without interposition graft) |
| 7 | Qualifier | Z | No Qualifier |
PCS Root Operations: Repair (Q) vs. Replacement (R)
- Use Repair (Q) with device value Z (No Device) when the perforation is closed using only bilateral mucosal flaps β no graft material is placed; the body partβs own tissue restores the anatomic barrier
- Use Replacement (R) with the appropriate device value when a tissue substitute is placed to replace or reinforce the septal structure β the choice of device character (7, J, or K) depends on whether the graft is autologous, synthetic, or nonautologous
- The PCS distinction between Repair and Replacement is significant in the inpatient DRG world β Replacement codes may drive higher resource intensity and affect DRG assignment when concurrent diagnoses are present
- When cartilage graft harvest is separately performed (e.g., conchal cartilage from the ear), assign an additional PCS code for the harvest using the appropriate root operation β typically Excision (B) β for the donor site body part in the addition to the nasal septum Replacement code
π Coding Examples
Example 1 β ASC: Post-Surgical Septal Perforation, Standard Repair
Clinical Scenario: A 42-year-old female presents with a 10-month history of bilateral nasal crusting, intermittent epistaxis, and a persistent audible nasal whistling sound. She underwent septoplasty 14 months ago for a deviated septum. Nasal endoscopy confirms a 9mm anterior cartilaginous septal perforation β consistent with opposing mucosal injuries from the prior septoplasty healing as a through-and-through defect. No active systemic disease. She is taken to the outpatient OR under general anesthesia. The surgeon performs bilateral mucoperichondrial advancement flaps via hemitransfixion incision. The perforation margins are freshened. Remaining intact septal cartilage is used as an autologous cartilage interposition graft (20912 harvest documented separately in the operative note). Bilateral mucosal closure is achieved in two layers. Quilting sutures placed. Internal nasal splints placed. Operative note confirms: β9mm anterior cartilaginous septal perforation repaired; bilateral mucoperichondrial flaps elevated and advanced; autologous cartilage graft from remaining caudal septal cartilage placed as interposition layer; two-layer mucosal closure achieved without tension.β
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 30630 | Repair nasal septal perforations β operative note confirms bilateral mucoperichondrial flap repair with autologous cartilage interposition; perforation size (9mm) documented |
| CPT 2 | 20912--51 | Cartilage graft; nasal septum β separately reportable autologous cartilage harvest from the remaining septal cartilage; modifier -51 = multiple procedures; confirm NCCI edit status; document donor site (nasal septum), amount harvested, and application |
| PDx | J34.89 | Other specified disorders of nose and nasal sinuses β acquired nasal septal perforation; no specific ICD-10-CM code exists for acquired perforation; document post-surgical etiology explicitly in the record |
Note
The cartilage graft harvest (20912) is a separately reportable service β the operative note must clearly document the harvest as a distinct step from the repair itself. If the operative note describes only βusing available septal cartilage as interpositionβ without documenting a distinct harvest procedure, 20912 may not be defensible as a separate code. The harvest should be documented with: the specific harvest site (remaining caudal septum), the method (sharp dissection under direct visualization), the graft dimensions, and its separate preparation before placement as interposition material.
Example 2 β Outpatient Hospital: Large Cocaine-Induced Perforation, Modifier 22, Concurrent Rhinoplasty
Clinical Scenario: A 37-year-old male presents with a 2.5 cm anterior septal perforation caused by chronic intranasal cocaine use β confirmed by history and toxicology. He has been documented cocaine-free for 18 months (confirmed by serial urine drug screens in the surgical record). Pre-operative exam also reveals significant saddle nose deformity from cartilage loss associated with the perforation. The surgical plan includes: (1) septal perforation repair using bilateral inferior turbinate mucosal rotational flaps (required due to inadequate adjacent mucosa for standard advancement flaps given the size of the perforation), and (2) structural rhinoplasty with rib cartilage graft to correct the saddle deformity. Operative time is 4 hours 15 minutes. The operative note explicitly documents: β2.5 cm perforation; adjacent mucosa insufficient for standard bilateral advancement; bilateral inferior turbinate mucosal rotational flaps designed and transposed; rib cartilage graft interposition placed; total operative time 4 hours 15 minutes.β
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 30630--22 | Repair nasal septal perforations; modifier -22 = substantially increased complexity β 2.5 cm perforation (large), inadequate adjacent mucosa requiring rotational flap technique rather than standard advancement, extended operative time (4h15m); cover letter and operative note attached |
| CPT 2 | 30450--51 | Rhinoplasty, secondary; major revision (nasal tip work and osteotomies) β structural rhinoplasty with rib graft for saddle nose deformity; -51 on the lower-valued code; confirm which rhinoplasty code matches the documented nasal subunit work |
| CPT 3 | 20900--51 | Bone graft, any donor area; minor or small β rib cartilage graft harvest (if βminorβ); or 20902 for major graft harvest β confirm graft size and donor site documentation to select the correct harvest code; -51 on lower-valued code |
| PDx | J34.89 | Other specified disorders of nose and nasal sinuses β large acquired nasal septal perforation; cocaine-induced etiology documented |
| SDx | F14.20 | Cocaine dependence, uncomplicated β documents the etiology; 18-month abstinence documented in the record; supports medical necessity for repair |
Warning
Modifier -22** on 30630 for a cocaine-induced perforation is clinically justified when the perforation is large (> 1.5 cm), the standard technique was insufficient, and the operative note documents these specific factors. Without all three elements β size, non-standard technique required, and extended operative time documented β the modifier will not survive payer review. Additionally, the cocaine cessation documentation is a medical necessity requirement: repair performed on a patient with active cocaine use will be denied by most payers and creates a liability exposure given the high recurrence rate. The surgical record must include pre-operative urine drug screen results confirming cessation before surgery.
Example 3 β Outpatient Hospital: GPA-Related Septal Perforation, Pre-Operative Rheumatology Clearance Documented
Clinical Scenario: A 51-year-old male with a known history of granulomatosis with polyangiitis (GPA/Wegenerβs) β managed with rituximab and maintained in remission confirmed by a rheumatology pre-operative clearance letter and negative ANCA titers within 30 days of surgery β presents for repair of a 12mm anterior septal perforation causing significant bilateral nasal crusting, obstruction, and recurrent epistaxis. The perforation developed over the course of his vasculitic disease process before diagnosis and treatment. Under general anesthesia, the surgeon performs bilateral mucoperichondrial advancement flaps with temporalis fascia interposition graft. The operative note documents: β12mm anterior septal perforation in the context of GPA in confirmed remission; bilateral mucoperichondrial advancement flaps elevated; temporalis fascia interposition graft placed; two-layer mucosal closure achieved; internal splints placed.β
| Field | Code | Rationale |
|---|---|---|
| CPT | 30630 | Repair nasal septal perforations β bilateral mucoperichondrial flap repair with temporalis fascia graft interposition; 12mm perforation |
| PDx | J34.89 | Other specified disorders of nose and nasal sinuses β acquired septal perforation; GPA-related etiology documented |
| SDx | M31.30 | Wegenerβs granulomatosis without renal involvement β documents the systemic etiology of the perforation; HCC code; confirmed in remission per rheumatology clearance; report as secondary |
| SDx | Z79.899 | Other long-term drug therapy β rituximab immunotherapy; documents the maintenance medication that achieved disease remission; clinically relevant to post-operative healing risk and follow-up plan |
Note
Pre-operative rheumatology clearance is a medical necessity documentation requirement for GPA-related repairs β payers will scrutinize claims for nasal repair in patients with active vasculitic disease. The surgical record must include: confirmed disease remission status (ANCA titers, clinical assessment), rheumatology clearance letter, and documentation that the repair is being performed for symptomatic relief of an established, controlled sequela. Without this documentation, the payer may argue that surgery was performed in the context of active disease, which could result in claim denial or a medical necessity audit. Additionally, the M31.30 HCC code must be reported on all claims where it affects the clinical picture β omitting it understates the patientβs complexity and may affect risk adjustment in value-based care contracts.
β οΈ Common Coding Pitfalls
-
Using 30630 when only 30520 is documented (septoplasty vs. perforation repair): The most common miscoding in the nasal septum surgery family is selecting 30630 when the operative note actually describes removal or repositioning of deviated cartilage for obstruction (30520) β or vice versa. 30630 requires documentation of a through-and-through perforation repaired with bilateral mucosal flaps or grafts. 30520 requires documentation of cartilage removal, scoring, or repositioning for a deviation. When both a deviation and a perforation exist and are both addressed in the same session, both codes may be appropriate β but each must be independently documented in the operative note, and the operative note must describe distinct repairs for each distinct problem. Using 30630 simply because the surgeon βworked on the septumβ without a documented perforation is a compliance violation.
-
Failing to separately report cartilage or fascia graft harvest codes with modifier -51: When the surgeon separately harvests autologous cartilage (20912 β septal, 21235 β conchal) or fascia for interposition, those harvest codes are separately reportable alongside 30630. A common billing gap is coding only 30630 and failing to capture the graft harvest code, which is a legitimate additional service with its own RVU. Conversely, coding the graft harvest without confirming a documented distinct harvest procedure (separate from the flap elevation itself) is overcoding. The operative note must describe the harvest as a distinct step to support the additional code.
-
Not applying modifier -22 for large perforations with documented complexity: 30630 has a single code regardless of perforation size β there is no size-stratified code family like there is for some soft tissue excisions. This means that the only mechanism to capture the substantially increased work of a large (> 1.5-2 cm), recurrent, or technically challenging perforation repair is modifier -22. Many providers perform these complex repairs without applying the modifier, leaving legitimate reimbursement unrealized. Educate surgeons to document: perforation size (measured in mm or cm), technique used (standard advancement vs. rotational/transposition flap), graft type, and total operative time β all of which are the building blocks of a defensible -22 claim.
-
Billing post-operative nasal debridement visits separately during the 90-day global: Nasal crusting and debris management after septal perforation repair is inherent to the post-operative course. Surgeons who perform nasal debridement under direct visualization at post-operative visits during the 90-day global period may attempt to separately bill 30901 (nasal hemorrhage control) or debridement codes β these services are bundled in the global payment for 30630 when they are part of the routine expected post-operative management. Only separate billing when the service clearly exceeds routine post-operative care: an unplanned OR return for a complication (-78) or an unrelated surgical procedure (-79).
-
Applying modifier -50 to 30630: A persistent misconception is that because the repair involves bilateral mucoperichondrial flaps (one on each side of the septum), it constitutes a βbilateralβ procedure subject to -50 billing. This is incorrect. The bilateral flaps are the technique for repairing a single anatomic defect β the nasal septum β not two separate bilateral structures. 30630 has a bilateral indicator of 0, and modifier -50 is never appropriate for this code. Billing 30630--50 is a claim error that will be rejected or recouped.
-
Defaulting to J34.89 without documenting etiology: While J34.89 is the only available code for most acquired nasal septal perforations, it must still be supported by a clear etiology statement in the clinical record. Payers, especially for cocaine-induced perforations, may require documentation of cessation before approving the repair. For GPA or other systemic disease etiologies, the systemic disease code (M31.30, D86.0) must be reported alongside J34.89 to convey the full clinical picture. Using J34.89 in isolation without the etiology-specific secondary diagnoses understates the complexity and may create medical necessity gaps in the record.
π Sources
AMA CPT 2025 Professional Edition Β· AMA Coderβs Desk Reference β Description of CPT 30630 Bilateral Mucoperichondrial Flap Technique Β· CMS 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F) and CMS RVU26A Relative Value Files Β· NCCI Policy Manual Chapter 5 (Respiratory System), CMS 2024-2025 Β· ICD-10-CM Official Guidelines for Coding and Reporting FY2025 Β· ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 Β· AAPC Otolaryngology Coding Alert β βIs This Codeable as a Repair or a Flap?β (AAPC, January 2007) Β· AAPC Otolaryngology Coding Alert β βUnderstand Repair or Correction for Correct Septoplasty Codingβ (AAPC, October 2024) Β· RVU Edge β CPT 30630 wRVU and RVU Breakdown (CMS RVU26A, March 2026) Β· GenHealth AI β CPT 30630 Clinical and ICD-10 Pairing Reference (2025) Β· MD Clarity β CPT 30630 Modifier and Reimbursement Reference (2025) Β· Noridian Medicare JE Part B β MPFS Indicator Descriptors (Global Period and Bilateral Indicator Reference)
Crystal's Coder Hub